The Institutional Biosafety Committee (IBC) includes oversight of experimentation that involves recombinant DNA, biological materials (e.g., infectious agents), and other potentially hazardous agents (e.g., carcinogens). Please submit an email to email@example.com if you have any questions or would like to submit an application for review.
IBC Meetings and Deadlines
IBC applications must be submitted before the deadlines listed below.
UPCOMING IBC MEETINGS
|Deadline for Submission||Meeting Date||Time|
|February 23, 2022||March 2, 2022||12:50 pm (virtually)|
|March 30, 2022||April 6, 2022||12:50 pm (virtually)|
|April 27, 2022||May 4, 2022||12:50 pm (virtually)|
More Information About Biosafety and Federal Requirements
Executive Officer – IBC Office